- Future Students
- Current Students
- Faculty & Staff
Filters: Keyword is Mycobacterium avium-intracellulare Infection [Clear All Filters]
Yamazaki Y, Danelishvili L, Wu M, Hidaka E, Katsuyama T, Stang BV, Petrofsky M, Bildfell RJ, Bermudez LE. 2006. The ability to form biofilm influences Mycobacterium avium invasion and translocation of bronchial epithelial cells.. Cellular microbiology. 8(5):806-14.
MacGregor RR, Hafner R, Wu JW, Murphy RL, Perlman DC, Bermudez LE, Inderlied CB, Picker LJ, Wallis RS, Andersen JW et al.. 2005. Clinical, microbiological, and immunological characteristics in HIV-infected subjects at risk for disseminated Mycobacterium avium complex disease: an AACTG study.. AIDS research and human retroviruses. 21(8):689-95.
Bermudez LE, Kolonoski P, Seitz LE, Petrofsky M, Reynolds R, Wu M, Young LS. 2004. SRI-286, a thiosemicarbazole, in combination with mefloquine and moxifloxacin for treatment of murine Mycobacterium avium complex disease.. Antimicrobial agents and chemotherapy. 48(9):3556-8.
Bermudez LE, Petrofsky M, Sangari F. 2004. Intracellular phenotype of Mycobacterium avium enters macrophages primarily by a macropinocytosis-like mechanism and survives in a compartment that differs from that with extracellular phenotype.. Cell biology international. 28(5):411-9.
Bermudez LE, Kolonoski P, Petrofsky M, Wu M, Inderlied CB, Young LS. 2003. Mefloquine, moxifloxacin, and ethambutol are a triple-drug alternative to macrolide-containing regimens for treatment of Mycobacterium avium disease.. The Journal of infectious diseases. 187(12):1977-80.